These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of vasoactive intestinal polypeptide infused intrapancreatically on glucagon and insulin secretion. Kaneto A; Kaneko T; Kajinuma H; Kosaka K Metabolism; 1977 Jul; 26(7):781-6. PubMed ID: 865285 [TBL] [Abstract][Full Text] [Related]
23. Effect of synthetic chicken vasoactive intestinal peptide on pancreatic blood flow and on exocrine and endocrine secretions of the pancreas in dogs. Inoue K; Kawano T; Shima K; Kim T; Suzuki T; Tobe T; Takeyama M; Yajima H Dig Dis Sci; 1983 Aug; 28(8):724-32. PubMed ID: 6347571 [TBL] [Abstract][Full Text] [Related]
24. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats. Szecówka J; Lins PE; Tatemoto K; Efendić S Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205 [TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreas. Sandberg E; Ahrén B; Tendler D; Efendic S Acta Endocrinol (Copenh); 1988 Apr; 117(4):545-51. PubMed ID: 3291528 [TBL] [Abstract][Full Text] [Related]
26. Effect of intrapancreatic administration of vasoactive intestinal peptide upon the release of insulin and glucagon in dogs. Ohneda A; Ishii S; Horigome K; Chiba M; Sakai T; Kai Y; Watanabe K; Yamagata S Horm Metab Res; 1977 Nov; 9(6):447-52. PubMed ID: 590919 [No Abstract] [Full Text] [Related]
27. Secretory effects of cholecystokinins on the isolated perfused porcine pancreas. Jensen SL; Rehfeld JF; Holst JJ; Nielsen OV; Fahrenkrug J; Schaffalitzky de Muckadell OB Acta Physiol Scand; 1981 Mar; 111(3):225-31. PubMed ID: 7032209 [TBL] [Abstract][Full Text] [Related]
28. Effects of PHI on hormonal secretion from perfused rat pancreas. Szecówka J; Tendler D; Efendić S Am J Physiol; 1983 Oct; 245(4):E313-7. PubMed ID: 6137956 [TBL] [Abstract][Full Text] [Related]
29. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241 [TBL] [Abstract][Full Text] [Related]
30. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach. Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859 [TBL] [Abstract][Full Text] [Related]
31. PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38). Tornøe K; Hannibal J; Fahrenkrug J; Holst JJ Am J Physiol; 1997 Aug; 273(2 Pt 1):G436-46. PubMed ID: 9277423 [TBL] [Abstract][Full Text] [Related]
32. Secretory effects of gastrins on isolated perfused porcine pancreas. Jensen SL; Rehfeld JF; Holst JJ; Fahrenkrug J; Nielsen OV; Schaffalitzky de Muckadell OB Am J Physiol; 1980 Feb; 238(2):E186-92. PubMed ID: 6987897 [TBL] [Abstract][Full Text] [Related]
33. Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. Konturek SJ; Pucher A; Radecki T J Physiol; 1976 Feb; 255(2):497-509. PubMed ID: 1255530 [TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and HCO3. Fahrenkrug J; Schaffalitzky de Muckadell OB; Holst JJ; Jensen SL Am J Physiol; 1979 Dec; 237(6):E535-40. PubMed ID: 517650 [TBL] [Abstract][Full Text] [Related]
35. Glucose-dependent effects of pancreastatin on insulin and glucagon release. von Schönfeld J; Kleimann J; Müller MK; Rünzi M; Goebell H Int J Pancreatol; 1991 Oct; 10(2):143-9. PubMed ID: 1748828 [TBL] [Abstract][Full Text] [Related]
36. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets. Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701 [TBL] [Abstract][Full Text] [Related]
37. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. Gerich JE; Charles MA; Grodsky GM J Clin Invest; 1974 Oct; 54(4):833-41. PubMed ID: 4430717 [TBL] [Abstract][Full Text] [Related]
38. Effect of dopamine on human gastric and pancreatic secretion. Valenzuela JE; Defilippi C; Diaz G; Navia E; Merino Y Gastroenterology; 1979 Feb; 76(2):323-6. PubMed ID: 759261 [TBL] [Abstract][Full Text] [Related]
39. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats. Wheeler S; Eardley JE; McNulty KF; Sutcliffe CP; Morrison JD Exp Physiol; 1997 Jul; 82(4):729-47. PubMed ID: 9257115 [TBL] [Abstract][Full Text] [Related]
40. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects. Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Nielsen OV; Lundberg JM; Hökfelt T Am J Physiol; 1987 Feb; 252(2 Pt 1):G182-9. PubMed ID: 3548423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]